Funding for this research was provided by:
Received: 22 May 2018
Accepted: 4 July 2018
First Online: 2 August 2018
Ethics approval and consent to participate
: The approval for this study was given by the regional ethical committee (Regional etisk komite Midt-Norge 2010/3078). No consent from patients was needed according to the ethical committee, as all the data described above were collected as part of clinical care to facilitate treatment decisions.
: Not applicable.
: GH is a founder and shareholder for DiaGraphIT AS, manufacturing the GoTreatIT® Rheuma software. The remaining authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.